（记者 王瀚黎） 每经头条（nbdtoutiao）——世界首例基因编辑猪肺成功移植人体 对话主要参与者：距离临床应用还有 多远？ 每经AI快讯，阿科力8月28日发布半年度业绩报告称，2025年上半年营业收入约2.14亿元，同比减少 11.63%；归属于上市公司股东的净利润亏损约531万元；基本每股收益亏损0.06元。 ...

Group 1 - The company announced the approval of multiple proposals, including the agenda for the 2025 semi-annual report, during the fifth meeting of the fifth board of directors [2]

格隆汇8月27日丨阿科力(603722.SH)发布2025年半年度报告，报告期实现营业收入2.14亿元，同比下降 11.63%；归属上市公司股东的净利润-531.12万元；扣除非经常性损益后的归属于上市公司股东的净利 润-702.58万元；基本每股收益-0.06元。 ...

一、会议召开情况 无锡阿科力科技股份有限公司（以下称"股份公司"）第五届董事会第五次会 议于 2025 年 8 月 27 日在公司办公楼二层会议室召开，会议的通知于 2025 年 8 月 11 日以电话、短信通知的方式发出。股份公司董事共计 9 人，出席本次董事 会的董事共 9 人，出席会议人数符合《中华人民共和国公司法》和《无锡阿科力 科技股份有限公司章程》的规定。 二、会议表决情况 1. 审议《关于公司 2025 年半年度报告的议案》； 内容详见同日于《上海证券报》、《证券时报》、《金融时报》及上海证券交易 所网站（www.sse.com.cn）刊登的《无锡阿科力科技股份有限公司 2025 年半年 度报告》、《无锡阿科力科技股份有限公司 2025 年半年度报告摘要》。 证券代码：603722 证券简称：阿科力 公告编号：2025-065 无锡阿科力科技股份有限公司 第五届董事会第五次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法 律责任。 本公司及监事会全体成员保证公告内容的真实、准确和完整，没 ...

Financial Performance - The company reported a half-year revenue of 500 million RMB, representing a 15% increase compared to the same period last year[15]. - The company's operating revenue for the first half of the year was ¥213,958,139.74, a decrease of 11.63% compared to ¥242,125,837.22 in the same period last year[22]. - The total profit for the period was -¥6,377,785.48, representing a decline of 381.35% from a profit of ¥2,266,868.00 in the previous year[24]. - The net profit attributable to shareholders was -¥5,311,185.86, down 367.84% from ¥1,982,939.20 year-on-year[22]. - Basic earnings per share were -¥0.06, a decline of 346.12% from ¥0.02 in the same period last year[23]. - The company's total assets decreased by 7.67% to ¥1,160,565,185.32 from ¥1,257,010,925.87 at the end of the previous year[22]. - The decline in revenue was primarily due to decreased sales volume and prices of the main product, polyether amine[24]. - The net cash flow from operating activities decreased by 606.92%, amounting to -¥76,088,149.57 compared to ¥15,009,747.78 in the previous year[24]. Market and Growth Strategy - User data indicates a growth in active users by 20%, reaching a total of 1 million users by the end of June 2025[15]. - The company has provided a performance guidance for the next half of the year, expecting a revenue growth of 10% to 12%[15]. - New product development includes the launch of a high-performance polymer line, projected to contribute an additional 50 million RMB in revenue[15]. - The company is expanding its market presence in Southeast Asia, targeting a 25% market share by 2026[15]. - A strategic acquisition of a local competitor is in progress, expected to enhance production capacity by 30%[15]. - The company is actively expanding its international market presence to enhance sales in the oil and gas sector[36]. - The company focuses on R&D investment to improve product quality and production efficiency, aiming for a "production generation, development generation, research generation, storage generation" strategy[32]. Research and Development - The company has invested 30 million RMB in R&D for new technologies aimed at reducing production costs by 15%[15]. - The high transparency material (COC) production line has completed trial production and is now in formal production, with initial products being tested by downstream clients[36]. - Research and development expenses decreased by 8.09% year-on-year to ¥6,445,818.03, reflecting a reduction in R&D investment[42]. - The company has been recognized as a national-level specialized and innovative "little giant" enterprise and has received multiple patents, including 30 authorized national invention patents and 1 U.S. invention patent[38]. Financial Position and Assets - The company's total assets decreased to CNY 1,097,691,262.75 from CNY 1,167,765,006.22 year-over-year[101]. - Total current assets decreased to ¥509,596,001.54 from ¥661,871,497.94, a decline of approximately 23%[94]. - Total non-current assets increased to ¥650,969,183.78 from ¥595,139,427.93, an increase of about 9%[95]. - The company’s financial assets decreased by 37.77% year-on-year to ¥140,237,734.82, mainly due to reduced investment in financial products[44]. Shareholder Information - The total number of ordinary shareholders as of the end of the reporting period is 5,974[86]. - The top ten shareholders hold a total of 45,000,000 shares, representing 47.80% of the total shares[88]. - Zhu Xuejun is the largest shareholder with 21,912,700 shares, accounting for 22.90% of the total shares[88]. - The company has no strategic investors or general legal entities becoming top ten shareholders due to new share placements[90]. Compliance and Governance - The company has established a governance structure including a shareholders' meeting, board of directors, and supervisory board[128]. - The company has committed to avoiding any business activities that may compete with its own operations, ensuring no direct or indirect competition[64]. - The company has established a long-term commitment to comply with regulations regarding related party transactions, ensuring fairness and legality[64]. - The company has received legal opinions confirming the compliance of its incentive plans with applicable laws[60]. Risks and Challenges - The company has identified potential risks in the industry, including supply chain disruptions and regulatory changes[15]. - The domestic competition in the polyether amine market is intensifying, with new capacities from competitors exceeding domestic demand[32]. - The company has not reported any significant updates on its poverty alleviation and rural revitalization efforts[62]. Cash Flow and Investments - The net cash flow from operating activities dropped significantly by 606.92%, resulting in a negative cash flow of ¥76,088,149.57, due to increased payments for subsidies and extended credit terms for good customers[42]. - The company’s investment activities generated a net cash flow of ¥17,069,364.01, primarily due to the recovery of matured financial products[43]. - The company plans to produce 2 million tons of polyether annually by 2025, with a total investment of 20,731.31 million RMB allocated for this project[76]. Accounting Policies - The accounting policies are aligned with enterprise accounting standards, ensuring accurate financial reporting[132]. - The company’s accounting period runs from January 1 to December 31 each year[133]. - The company recognizes minority interests in subsidiaries separately in the consolidated balance sheet and reports the share of minority interests in net profit under "minority shareholder profit" in the consolidated income statement[139].

本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 重要提示： ●"年产 2000 吨特种冷却液项目"（以下简称"本项目"）尚处于前期准备 阶段。受国家政策法规、政府机构审批进度、公司资金状况等多种因素影响，本 项目开工建设时间、具体实施进度等均存在一定的不确定性。 证券代码：603722 证券简称：阿科力 公告编号：2025-068 无锡阿科力科技股份有限公司关于全资子公司取得 《湖北省固定资产投资项目备案证》的公告 ●未来可能存在市场、政治、经济等不可预判或不可抗力等不确定因素及一 定的管理风险，从而影响本项目建设进度、预计收益等情况。 一、投资项目备案的基本情况 近日，无锡阿科力科技股份有限公司（以下简称"公司"）全资子公司阿科力 科技（潜江）有限公司收到潜江市发展和改革委员会签发的《湖北省固定资产投 资项目备案证》，具体内容如下： 项目名称：年产 2000 吨特种冷却液项目 项目单位：阿科力科技（潜江）有限公司 登记备案项目代码：2508-429005-04-01-781887 项目单位性质：其他 ...

无锡阿科力科技股份有限公司关于 2025 年 半年度募集资金存放与实际使用情况的专项报告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 证券代码：603722 证券简称：阿科力 公告编号：2025-066 根据中国证券监督管理委员会《上市公司募集资金监管规则》、《上海证券 交易所上市公司自律监管指引第 1 号——规范运作》及相关公告格式规定，现将 本公司 2025 年半年度募集资金存放与使用情况报告如下： 一、募集资金基本情况 （一）实际募集资金金额和资金到位时间 经中国证券监督管理委员会《关于同意无锡阿科力科技股份有限公司向特定 对象发行股票注册的批复》（证监许可〔2024〕1011 号）核准，并经上海证券 交易所同意，本公司向特定对象非公开发行人民币普通股（A 股）股票 7,762,621 股，发行价为每股人民币 27.72 元，共计募集资金 215,179,854.12 元，扣除发行 费用（不含税）7,866,711.65 元后，募集资金净额为 207,313,142.47 元。 上述募集资金已 ...

证券代码：603722 证券简称：阿科力 公告编号：2025-067 无锡阿科力科技股份有限公司 关于 2025 年度"提质增效重回报"行动方案 半年度评估报告的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、 优化主业结构，提升经营质效 公司核心业务是聚醚胺、光学级聚合物材料用树脂、高透光材料等化工新 材料产品的研发、生产和销售。国内风电叶片用聚醚胺竞争加剧的情况下，公 司积极主动转型，迎合市场需求，开发特殊牌号的聚醚胺。同时，公司继续保 持油气开采领域国内领先地位，并成立香港子公司，加强特殊牌号聚醚胺的出 口销售，积极开拓国际市场。在光学级聚合物材料用树脂领域，丙烯酸异冰片 酯和甲基丙烯酸异冰片酯等产品，凭借光泽感、高硬度等优点，广泛应用于高 端汽车表面光固化涂层，公司会持续扩大在汽车涂料领域的市场份额，并积极 争取其他涂料领域的应用。高透光材料（环烯烃共聚物）千吨级生产线已经完 成试生产进入正式生产阶段，有少量产品产出，现已联系下游药用包材、光学 镜头等领域客户并送样测试。阿科力潜江项目也在稳步推进过程中 ...

2025 年半年度主要经营数据公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 无锡阿科力科技股份有限公司（以下简称"公司"）根据上海证券交易所 《上市公司行业信息披露指引第十三号——化工》（2022 年修订）和《关于做 好主板上市公司 2025 年半年度报告披露工作的重要提醒》要求，现将 2025 年 半年度主要经营数据披露如下： 证券代码：603722 证券简称：阿科力 公告编号：2025-064 无锡阿科力科技股份有限公司 二、报告期内主要产品和原材料的价格变动情况 特此公告！ 无锡阿科力科技股份有限公司 | 主要原材料 | 2025 | 年 1-6 | 月平均采 | 2024 | 年 1-6 | 月平均采 | 变动比率 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | 购均价（元/吨） | | | 购均价（元/吨） | | | | 环氧丙烷 | | 6,898.70 | | | 8,366.70 | | -17.55% | | ...

阿科力公告，全资子公司阿科力科技（潜江）有限公司收到潜江市发展和改革委员会签发的《湖北省固 定资产投资项目备案证》。项目名称为"年产2000吨特种冷却液项目"，项目总投资2000万元，计划开工 时间为2025年10月。新建设特种冷却液生产装置两套，纯水处理装置一套，以及配套的废水、废气等环 保装置，建成后可达成年产特种冷却液2000吨规模。本项目投资符合国家产业政策、公司战略发展规 划，对公司的中长期发展将产生积极影响。 ...